Aberdeen Asset Management’s Dentsply Sirona XRAY Stock Holding History

Aberdeen Asset Management’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$2.62M	Sell	40,386 -3,368	-8%	-$213K	0.01%	568
2017 Q1	$2.73M	Buy	43,754 +1,778	+4%	+$107K	0.01%	547
2016 Q4	$2.42M	Sell	41,976 -16,109	-28%	-$952K	0.01%	545
2016 Q3	$3.45M	Sell	58,085 -510	-0.9%	-$31.3K	0.01%	497
2016 Q2	$3.63M	Sell	58,595 -283	-0.5%	-$17.4K	0.01%	476
2016 Q1	$3.63M	Buy	58,878 +32,961	+127%	+$1.94M	0.01%	472
2015 Q4	$1.52M	Buy	25,917 +3,982	+18%	+$237K	0.01%	595
2015 Q3	$1.11M	Sell	21,935 -180	-0.8%	-$9.59K	﹤0.01%	581
2015 Q2	$1.14M	Sell	22,115 -136	-0.6%	-$7.04K	﹤0.01%	583
2015 Q1	$1.13M	Sell	22,251 -1,675	-7%	-$86.4K	﹤0.01%	598
2014 Q4	$1.27M	Sell	23,926 -100,872	-81%	-$5.13M	﹤0.01%	594
2014 Q3	$5.69M	Sell	124,798 -2,251	-2%	-$106K	0.01%	405
2014 Q2	$6.02M	Buy	127,049 +114,049	+877%	+$5.31M	0.01%	425
2014 Q1	$599K	Sell	13,000 -79,800	-86%	-$3.69M	﹤0.01%	542
2013 Q4	$4.49M	Sell	92,800 -85,100	-48%	-$3.98M	0.01%	198
2013 Q3	$7.72M	Hold	177,900	–	–	0.02%	132
2013 Q2	$7.29M	Buy	+177,900	New	+$7.42M	0.02%	140

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Aberdeen Asset Management's XRAY Position: Q2 2017 in Review

Aberdeen Asset Management reduced its Dentsply Sirona (XRAY) stake by 7.7% in Q2 2017, selling an estimated $213K and leaving 40,386 shares worth $2.62M. The position accounts for 0.01% of the portfolio, ranked #568.

Aberdeen Asset Management first reported a position in XRAY in Q2 2013 and has held it in 17 quarters since. The position peaked at $7.72M in Q3 2013. 548 funds tracked by Wall St. Rank hold XRAY as of Q2 2017.

Aberdeen Asset Management held 40,386 shares of Dentsply Sirona worth $2.62M as of Q2 2017.
Aberdeen Asset Management sold 3,368 Dentsply Sirona shares in Q2 2017, an estimated $213K.
Dentsply Sirona made up 0.01% of Aberdeen Asset Management's portfolio in Q2 2017, its #568 holding.
Aberdeen Asset Management first reported a position in Dentsply Sirona in Q2 2013 and has held it in 17 quarters since.
Aberdeen Asset Management's Dentsply Sirona position peaked at $7.72M in Q3 2013.
548 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.